Compare ARK Genomic Revolution ETF (ARKG) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Tenet Healthcare Corporation — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while Tenet Healthcare Corporation trades at $259.45 (market cap $20.89B). Which is the better fit depends on your goals.
| ARKG | THC | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $262.63 |
52-Week Low | $24.02 | $161.37 |
Market Cap | — | $20.89B |
Enterprise Value | — | $31.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
